Zolmitriptan - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for zolmitriptan and what is the scope of patent protection?
Zolmitriptan
is the generic ingredient in three branded drugs marketed by Padagis Israel, Amneal, Alembic, Apotex Inc, Glenmark Pharms Ltd, Jubilant Generics, Macleods Pharms Ltd, Rising, Zydus Pharms Usa Inc, Astrazeneca, Ajanta Pharma Ltd, Ani Pharms, Appco, Aurobindo Pharma, Invagen Pharms, Natco Pharma Usa, Orbion Pharms, Pld Acquisitions Llc, Sun Pharma Global, Zydus Pharms, and IPR, and is included in twenty-six NDAs. Additional information is available in the individual branded drug profile pages.There are twenty drug master file entries for zolmitriptan. Twenty-one suppliers are listed for this compound.
Summary for zolmitriptan
US Patents: | 0 |
Tradenames: | 3 |
Applicants: | 21 |
NDAs: | 26 |
Drug Master File Entries: | 20 |
Finished Product Suppliers / Packagers: | 21 |
Raw Ingredient (Bulk) Api Vendors: | 99 |
Clinical Trials: | 23 |
Patent Applications: | 6,643 |
Drug Prices: | Drug price trends for zolmitriptan |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for zolmitriptan |
What excipients (inactive ingredients) are in zolmitriptan? | zolmitriptan excipients list |
DailyMed Link: | zolmitriptan at DailyMed |
Recent Clinical Trials for zolmitriptan
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Parc de Salut Mar | Phase 1 |
Food and Drug Administration (FDA) | Phase 1 |
William Stoops | Early Phase 1 |
Pharmacology for zolmitriptan
Drug Class | Serotonin-1b and Serotonin-1d Receptor Agonist |
Mechanism of Action | Serotonin 1b Receptor Agonists Serotonin 1d Receptor Agonists |
Anatomical Therapeutic Chemical (ATC) Classes for zolmitriptan
Paragraph IV (Patent) Challenges for ZOLMITRIPTAN
Tradename | Dosage | Ingredient | Strength | NDA | ANDAs Submitted | Submissiondate |
---|---|---|---|---|---|---|
ZOMIG | Nasal Spray | zolmitriptan | 2.5 mg/spray | 021450 | 1 | 2016-06-09 |
ZOMIG | Nasal Spray | zolmitriptan | 5 mg/spray | 021450 | 1 | 2013-11-14 |
US Patents and Regulatory Information for zolmitriptan
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Macleods Pharms Ltd | ZOLMITRIPTAN | zolmitriptan | TABLET, ORALLY DISINTEGRATING;ORAL | 204336-002 | Oct 22, 2015 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Rising | ZOLMITRIPTAN | zolmitriptan | TABLET, ORALLY DISINTEGRATING;ORAL | 202855-002 | Sep 20, 2019 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Glenmark Pharms Ltd | ZOLMITRIPTAN | zolmitriptan | TABLET;ORAL | 201779-001 | May 14, 2013 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Jubilant Generics | ZOLMITRIPTAN | zolmitriptan | TABLET;ORAL | 202279-001 | Nov 20, 2014 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for zolmitriptan
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Amneal | ZOMIG | zolmitriptan | SPRAY;NASAL | 021450-004 | Sep 30, 2003 | ⤷ Sign Up | ⤷ Sign Up |
Amneal | ZOMIG | zolmitriptan | SPRAY;NASAL | 021450-003 | Sep 16, 2013 | ⤷ Sign Up | ⤷ Sign Up |
Ipr | ZOMIG | zolmitriptan | TABLET;ORAL | 020768-002 | Nov 25, 1997 | ⤷ Sign Up | ⤷ Sign Up |
Ipr | ZOMIG | zolmitriptan | TABLET;ORAL | 020768-001 | Nov 25, 1997 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.